期刊文献+

p16、DAPK和RARβ基因启动子CpG岛甲基化与非小细胞肺癌临床特征的关系 被引量:5

Relationship between promoter methylation of p16, DAPK and RARβ genes and the clinical data of non-small cell lung cancer
原文传递
导出
摘要 目的研究非小细胞肺癌(non-smal cell lung cancer,NSCLC)患者p16、DAPK和RARβ启动子区CpG岛甲基化对临床特征的影响,探讨其与吸烟的关系。方法应用甲基化特异性PCR检测200例原发性NSCLC组织和相应正常组织中p16,DAPK和RARβ基因启动子区CpG岛甲基化状况。结果p16、DAPK和RARβ基因甲基化在癌组织中的检出率分别为51.0%、60.0%和58.0%,均高于其在正常组织中的检出率(分别为12.5%,11.5%和15.0%;P〈0.05)。非条件Logistic回归显示,癌组织p16基因甲基化与年龄和病例组织类型有关(P〈0.05);癌组织DAPK基因甲基化与年龄、性别、临床分类有关(P〈0.05);而癌组织RARβ基因甲基化与临床分类和TNM(tumor node metastasis)分期相关(P〈0.05)。癌组织p16基因甲基化与DAPK基因甲基化之间存在交互作用(0R=1.987,95%CI:1.055~3.743)。吸烟者癌组织p16和DAPK基因甲基化的0R值分别为3.139(95%CI:1.046~9.419)和3.585(95%CI:1.270~10.123),未发现癌组织RARβ基因甲基化与吸烟有关。结论p16,DAPK和RARβ甲基化与NSCLC患者临床特征关系密切。吸烟与p16和DAPK基因甲基化有关。 Objective To investigate the effects of promoter methylation of p16 , death-associated protein kinase (DAPK) and retinoic acid receptor-β (RARβ) genes on clinical data in non-small cell lung cancers, and to study the effect of smoking on the risk of gene methylation. Methods The promoter methylation of p16 , DAPK and RARβ genes in 200 primary non-small cell lung cancers and the corresponding nonmalignant lung tissues were determined by methylation-specific PCR. Results Methylation in the tumor tissues was detected in 51.0% for p16 , 60.0% for DAPK, and 58.0% for RARβ gene, with significant differences (P〈 0. 05) when compared with those in the corresponding nonmalignant tissues (12.5%,11.5% and 15.0%) respectively, p16 gene methylation in tumor tissue was associated with age significantly in unconditional logistic regression analysis (P〈(0.01) and histologic type (P〈0.05). DAPK gene methylation in tumor tissue was associated significantly with age (P〈0.05), gender (P〈0.05) and clinical type (P〈0. 05). RARβ gene methylation in tumor tissue was associated with clinical type (P〈 0.05) and tumor stage (P〈0.05) significantly. The interaction odds ratio (OR) for the gene-gene interaction in tumor tissue between p16 and DAPK was 1. 987 (95%CI: 1. 055-3. 743). The results of the gene-smoking analyses revealed that a relationship existed between cigarette smoking and p16 gene methylation (OR: 3. 139, 95 %CI:1. 046-9. 419), the OR for the relationship of DAPK gene methylation and cigarette smoking was 3. 585 (95 %CI:1. 270-10. 123)in tumor tissue. The RARβ gene methylation did not differ based on the smoking status of patients in tumor tissue. Conclusion Thep16 , DAPK and RARβ genes methylation are strongly associated with clinical data of non-small cell lung cancer, and methylation of p16 and DAPK genes are associated with tobacco smoking.
出处 《中华医学遗传学杂志》 CAS CSCD 北大核心 2011年第1期23-28,共6页 Chinese Journal of Medical Genetics
基金 浙江省自然科学基金杰出青年研究团队项目(R207067) 国家自然科学基金(81072257) 中央高校基本科研业务费专项基金(2010QNA7017)
关键词 非小细胞肺癌 甲基化 P16基因 DAPK基因 RARβ基因 non-small cell lung cancer methylation p16 gene DAPK gene RARβ gene
  • 相关文献

参考文献22

  • 1Dammann R, Strunnikova M, Schagdarsurengin U, et al. CpG island methylation and expression of tumour-associated gene in lung carcinoma. Eur J Cancer, 2005,41 : 1223-1236.
  • 2Wang Y,Zhang D,Zheng W,et al. Multiple gene methylation of non small cell lung cancers evaluated with 3-dimensional microarray. Cancer, 2008,112 : 1325-1336.
  • 3Feng Q, Hawes SE, Stern JE, et al. DNA methylation in tumor and matched normal tissues from non-small cell lung cancer patients. Cancer Epidemiol Biomarkers Prey, 2008,17 : 645-654.
  • 4Zochbauer-Muller S, Fong KM, Virmani AK, et al. Aberrant promoter methylation of multiple genes in non small cell lung cancers. Cancer Res, 2001,61..249-255.
  • 5Yanagawa N, Tamura G, Oizuml H, et al. Promoter hypermethylation of RASSF1A and RUNX3 genes as an independent prognostic prediction marker in surgically resected non-small cell lung cancers. Lung Cancer, 2007,58.. 131-138.
  • 6Toyooka S, Maruyama R, Toyooka KO, et al. Smoke exposure, histologic type and geography-related differences in the methylation profiles of non-small cell lung cancer. Int J Cancer, 2003, 103:153-160.
  • 7Gilbert SF. Ageing and cancer as diseases of epigenesis. J Bioscl, 2009,34 :601-604.
  • 8Nishida N, Nagasaka T, Nishimura T, et al. Aberrant methylation of multiple tumor suppressor genes in aging liver, chronic hepatitis, and hepatocellular carcinoma. Hepatology, 2008, 47:908-918.
  • 9Issa JP. CpG island methylator phenotype in cancer. Nat Rev Cancer, 2004,4:988-993.
  • 10Kirsch-Volders M, Bonassi S, Herceg Z, et al. Gender-related differences in response to mutagens and carcinogens. Mutagenesis, 2010,25 :213-221.

同被引文献57

  • 1陈汉春,胡维新.环境因素对肺癌发生的影响[J].生命科学研究,2006,10(S1):112-114. 被引量:9
  • 2刘永煜.重组人血管内皮抑素治疗晚期非小细胞肺癌Ⅲ期临床研究[J].中国肿瘤,2005,14(6):398-400. 被引量:35
  • 3孔云明,金永堂,薛绍礼,于在诚,徐迎春,陶文虎,汪亚松,侯勇.NSCLC患者血浆p16和MGMT基因甲基化检测及临床意义[J].肿瘤,2007,27(9):715-718. 被引量:7
  • 4Lander ES, Linton LM, Birren B, et al. Initial sequencing and analysis of the human genome[J]. Nature, 2001,409:860-921.
  • 5Cordaux R, Batzer MA. The impact of retrotransposons on human genome evoIution[-J]. Nat Rev Genet, 2009,10 : 691-703.
  • 6Babushok DV, Kazazian HH Jr. Progress in understanding the biology of the human mutagen LINE-I[J]. Hum Mutat, 2007, 28:527-39.
  • 7Baba Y, Huttenhower C, Nosho K, et al. Epigenomic diversity of colorectal cancer indicated by LINE-1 methylation in a database of 869 tumors[J]. Mol Cancer, 2010,9:125.
  • 8Baba Y, Huttenhower C, Nosho K, et al. Epigenomic diversity of colorectal cancer indicated by Line-1 methylation in a data base of 869 tumors[J]. Mol Cancer, 2010, 9:125.
  • 9Pattamadilok J, Huapai N, Rattanatanyong P, et al. LINE-1 hypomethylation level as a potential prognostic {actor for epithelial ovarian cancer [J]. nt J Gynecol Cancer, 2008, 18 : 711-717.
  • 10Kwon HJ, Kim JH, Bae JM, et aI. DNA methylation changes in ex-adenoma carcinoma of the large intestine E J. Virchows Archiv, 2010,457:433-441.

引证文献5

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部